Analystreport

Constellation Pharmaceuticals, Inc. (NASDAQ: CNST) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating.

Constellation Pharmaceuticals, Inc  (CNST) 
Last constellation pharmaceuticals, inc earnings: 3/10 04:12 pm Check Earnings Report